Safety and efficacy of lixisenatide vs sulfonylurea added to basal insulin in patients with type 2 diabetes who fast during Ramadan (LixiRam): a randomised controlled trial

被引：0
|
作者：
Hassanein, M. M. [1 ]
Hafidh, K. [2 ]
Shehadeh, N. [3 ]
Azar, S. [4 ]
Hanif, W. [5 ]
Li, H. [6 ]
Djaballah, K. [7 ]
Sahay, R. [8 ]
机构：
[1] Dubai Hosp, Dubai, U Arab Emirates
[2] Rashid Hosp, Dubai, U Arab Emirates
[3] Rambam Med Ctr, Haifa, Israel
[4] Amer Univ Beirut, Med Ctr, Beirut, Lebanon
[5] Univ Hosp Birmingham, Birmingham, W Midlands, England
[6] Sanofi Aventis China, Beijing, Peoples R China
[7] Sanoti, Paris, France
[8] Osmania Med Coll & Hosp, Hyderabad, Telangana, India
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
757
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of lixisenatide vs sulphonylurea added to basal insulin in Indian patients with type 2 diabetes who fast during Ramadan in the LixiRam randomised trial
    Sahay, R.
    Hafidh, K.
    Djaballah, K.
    Azar, S.
    Shehadeh, N.
    Hanif, W.
    Hassanein, M. M.
    DIABETOLOGIA, 2019, 62 : S372 - S373
  • [2] Safety of lixisenatide versus sulfonylurea added to basal insulin treatment in people with type 2 diabetes mellitus who elect to fast during Ramadan (LixiRam): An international, randomized, open-label trial
    Hassanein, Mohamed M.
    Sahay, Rakesh
    Hafidh, Khadija
    Djaballah, Khier
    Li, Haoyu
    Azar, Sami
    Shehadeh, Naim
    Hanif, Wasim
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 150 : 331 - 341
  • [3] Safety of lixisenatide plus basal insulin treatment regimen in Indian people with type 2 diabetes mellitus during Ramadan fast: A post hoc analysis of the LixiRam randomized trial
    Sahay, Rakesh
    Hafidh, Khadijah
    Djaballah, Khier
    Coudert, Mathieu
    Azar, Sami
    Shehadeh, Naim
    Hanif, Wasim
    Hassanein, Mohamed
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
  • [4] Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study
    Seino, Y.
    Ikeda, Y.
    Niemoeller, E.
    Watanabe, D.
    Takagi, H.
    Yabe, D.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (12) : 895 - 900
  • [5] Indirect comparison of efficacy and safety of insulin glargine/lixisenatide and insulin degludec/insulin aspart in type 2 diabetes patients not controlled on basal insulin
    Jammah, Anwar Ali
    PRIMARY CARE DIABETES, 2021, 15 (01) : 132 - 137
  • [6] EFFICACY AND SAFETY OF LIRAGLUTIDE VS PLACEBO WHEN ADDED TO BASAL INSULIN ANALOGUES IN SUBJECTS WITH TYPE 2 DIABETES (LIRA-ADD2BASAL): A RANDOMISED, PLACEBO-CONTROLLED TRIAL
    Ahmann, A.
    Rosenstock, J.
    Rodbard, H.
    Lahtela, J.
    de Loredo, L.
    Tornoe, K.
    Wang, F.
    Nauck, M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S254 - S255
  • [7] Efficacy and safety of liraglutide vs placebo when added to basal insulin analogues in subjects with type 2 diabetes (LIRA-ADD2BASAL): a randomised, placebo-controlled trial
    Lahtela, J.
    Ahmann, A.
    Rodbard, H.
    Rosenstock, J.
    de Loredo, L.
    Tornoe, K.
    Boopalan, A.
    Nauck, M.
    DIABETOLOGIA, 2014, 57 : S21 - S22
  • [8] Efficacy and safety of insulin degludec/insulin aspart vs biphasic insulin aspart 30: an international randomised trial in adults with type 2 diabetes fasting during Ramadan
    Hassanin, M.
    Echtay, A.
    Malek, R.
    Omar, M.
    Shaikh, S.
    Fita, E. G.
    Kaplan, K.
    Kamaruddin, N.
    DIABETOLOGIA, 2017, 60 : S75 - S75
  • [9] Efficacy and Safety of Liraglutide vs. Sulfonylurea Both in Combination with Metformin during Ramadan in Subjects with Type 2 Diabetes (LIRA-Ramadan): A Randomized Trial
    Azar, Sami
    Echtay, Akram
    Bebakar, Wan Mohamad W.
    Al Araj, Sumayya
    Berrah, Abdelkrim
    Omar, Mohamed
    Mutha, Abhay
    Tornoe, Karen
    Kaltoft, Margit
    Shehadeh, Naim
    DIABETES, 2015, 64 : A288 - A288
  • [10] SAFETY AND EFFICACY OF INSULIN GLARGINE/LIXISENATIDE AND INSULIN DEGLUDEC/INSULIN ASPART IN TYPE 2 DIABETES PATIENTS NOT CONTROLLED ON BASAL INSULIN: A NETWORK META-ANALYSIS
    Jammah, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A185 - A186
12345